Position in NEO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,096,205
+$12,120,678 QoQ
Shares Held
2,131,337
-16.7% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#20
of 265 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SAMLYN CAPITAL, LLC holds $115,394,460 across 2 Diagnostics & Research names. NEO ranks #2 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
561,876 | $84,298,255 | |
| 2 | NEO |
Neogenomics Inc
This page
|
2,131,337 | $31,096,205 |
All Filings in NEO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,096,205 | 2,131,337 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,975,527 | 2,557,349 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,325,477 | 1,388,221 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||